SERVICES

Archive | Ophthalmology and Vision

Press Release: Alejandro Arboleda Named 2018 Koch Kellan Scholar

PORTLAND, Ore., April 13, 2018 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., an ophthalmic pharmaceutical and medical device company, announced today that Alejandro Arboleda has been named its 2018 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to elevating the standard of eye […]

Continue Reading

Press Release: EyeBuyDirect Launches Winter Whims 2017 Fall-Winter Collection

AUSTIN, Texas, Nov. 17, 2017 (SEND2PRESS NEWSWIRE) — The fastest growing online eyewear retailer, EyeBuyDirect, has launched its new collection, Winter Whims. The collection includes 21 frames that embody the colors, textures and feeling of winter. The new Winter Whims collection is available online now. It features chocolate-brown and cinnamon-red frames that invoke the smell […]

Continue Reading

Press Release: Paragon BioTeck Calls Emerging Leaders to Apply for 2018 Ophthalmology Scholarship

PORTLAND, Ore., Oct. 2, 2017 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately-held pharmaceutical and medical device company, today announced the call for the next Koch Kellan Scholar. The annual Koch Kellan Scholarship honors one outstanding graduate medical student committed to elevating the standard of eye care through social responsibility and a clinical, teaching, or […]

Continue Reading

Press Release: Xinxin Zhang Named 2017 Koch Kellan Scholar

PORTLAND, Ore., April 12, 2017 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., an ophthalmic pharmaceutical and device company, announced today that Xinxin Zhang has been named its 2017 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to pursuing a clinical, teaching or research […]

Continue Reading

Press Release: Ruling Affirms Patent Claim for Paragon BioTeck’s R-Phenylephrine Hydrochloride Formulation

PORTLAND, Ore., Nov. 21, 2016 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc. (Paragon), announces a monumental ruling handed down by the United States Patent and Trademark Office affirming claims made by Paragon in the patent for its R-phenylephrine hydrochloride formulation. Paragon is a privately held pharmaceutical and medical device company specializing in the development and commercialization […]

Continue Reading

Paragon BioTeck, Inc. Announces Call for 2017 Koch Kellan Scholarship Applicants

PORTLAND, Ore., Sept. 1, 2016 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, announced today a call for applications for the 2017 Koch Kellan Scholarship, awarded annually to an outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology. A Paragon Gives initiative, the […]

Continue Reading
ophthalmic pharmaceuticals

Paragon BioTeck to Exhibit at American Academy of Ophthalmology Annual Meeting in Chicago

PORTLAND, Ore., Oct. 15, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, will be exhibiting at the American Academy of Ophthalmology (Booth #4550) in Chicago, Ill., on October 18 – 21.

Continue Reading

Novel Protein May Hold Promise for Enhancing Artificial Tear Formulations

PLYMOUTH, Minn., Oct. 14, 2014 (SEND2PRESS NEWSWIRE) — SilkTears, LLC, a privately held, research-based and product-driven biotechnology company, announced today that advances in protein-based excipient technology may allow for the development of artificial tear products that will more closely represent certain characteristics of the natural makeup of the tear film, and may help the significant […]

Continue Reading
Ophthalmic Solution

Paragon BioTeck announces FDA Approved Phenylephrine Hydrochloride Ophthalmic Solution Readily Available

PORTLAND, Ore., June 4, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held U.S. biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, announces its FDA approved Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent, to dilate the pupil, is readily available through Bausch + Lomb or your primary wholesaler.

Continue Reading
Cataract Surgery

Southgate Surgery Center Offers LENSAR Advanced Laser Technology for Cataract Surgery Patients

SOUTHGATE, Mich., April 8, 2014 (SEND2PRESS NEWSWIRE) — Southgate Surgery Center in Southgate, Michigan is now offering patients the FDA-approved LENSAR(TM) Laser System, a new femtosecond laser technology designed to remove cataracts and restore vision more safely and accurately than traditional cataract surgery.

Continue Reading

Part of the Neotrope® News Network, USA. Neotrope.net